1. Home
  2. BIRD vs ATNM Comparison

BIRD vs ATNM Comparison

Compare BIRD & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRD
  • ATNM
  • Stock Information
  • Founded
  • BIRD 2015
  • ATNM 2000
  • Country
  • BIRD United States
  • ATNM United States
  • Employees
  • BIRD N/A
  • ATNM N/A
  • Industry
  • BIRD Apparel
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BIRD Consumer Discretionary
  • ATNM Health Care
  • Exchange
  • BIRD Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • BIRD 50.7M
  • ATNM 46.5M
  • IPO Year
  • BIRD 2021
  • ATNM N/A
  • Fundamental
  • Price
  • BIRD $5.15
  • ATNM $1.30
  • Analyst Decision
  • BIRD Buy
  • ATNM Strong Buy
  • Analyst Count
  • BIRD 3
  • ATNM 4
  • Target Price
  • BIRD $12.00
  • ATNM $8.75
  • AVG Volume (30 Days)
  • BIRD 68.5K
  • ATNM 1.2M
  • Earning Date
  • BIRD 05-08-2025
  • ATNM 04-29-2025
  • Dividend Yield
  • BIRD N/A
  • ATNM N/A
  • EPS Growth
  • BIRD N/A
  • ATNM N/A
  • EPS
  • BIRD N/A
  • ATNM N/A
  • Revenue
  • BIRD $189,757,000.00
  • ATNM N/A
  • Revenue This Year
  • BIRD N/A
  • ATNM N/A
  • Revenue Next Year
  • BIRD $4.60
  • ATNM N/A
  • P/E Ratio
  • BIRD N/A
  • ATNM N/A
  • Revenue Growth
  • BIRD N/A
  • ATNM N/A
  • 52 Week Low
  • BIRD $3.93
  • ATNM $1.03
  • 52 Week High
  • BIRD $18.34
  • ATNM $10.24
  • Technical
  • Relative Strength Index (RSI)
  • BIRD 48.45
  • ATNM 48.76
  • Support Level
  • BIRD $4.56
  • ATNM $1.17
  • Resistance Level
  • BIRD $5.05
  • ATNM $1.34
  • Average True Range (ATR)
  • BIRD 0.59
  • ATNM 0.13
  • MACD
  • BIRD 0.03
  • ATNM -0.01
  • Stochastic Oscillator
  • BIRD 51.17
  • ATNM 44.00

About BIRD Allbirds Inc.

Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: